Sat, Nov 29, 2014, 4:08 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Titan Pharmaceuticals Inc. Message Board

  • mdpetrosky mdpetrosky Oct 12, 2013 8:22 PM Flag

    Zacks would not put a strong buy on TTNP if they were worried about about the RSI at 50 cent.

    Since the stock was in a trading range for 6 months from 50 to 55 cents it threw the RSI off or mess with it. To give a false positive or higher number then it is and Zacks still rates it a strong buy at a dollar. Who do you believe ZACKS or the software.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • zack's strong buy is SHORT TERM, 1-3 months, and it's been almost a month i think, and it was prior to the 30% jump. i dont know if we could stay it is still a strong buy

    • apparently, you are under the impression that Zacks is a legitimate source for stock info.

    • Zacks SELLS those reports you mention and like any rag worth its price, it knows sensationalism sells. JN (Titan's resident so-called Zacks analyst) is proven and WELL DOCUMENTED to be arithmetically challenged, in fact, comically so. NOT JUST THAT but at former CCs, old JN's live performances have been top-notch behind-kissing spectacles. Frankly, his is about the only entertainment break shareholders have experienced in the overall dismal and otherwise poorly executed Titan CCs. Coincidentally (or maybe not) he also seems to be called upon with some regularity, and to the notorious exclusion of others (can we say retail shareholders to start?). And HE ALWAYS asks leading and solicitous (as in pandering near gushing) questions, which in turn are gleefully answered with near-rehearsed precision by Titan management. All-in-all, my trust level of Zacks is about on par with that of the Democratic Party......

0.4630.000(0.00%)Oct 30 2:14 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.